Effects of renal denervation on blood pressure in hypertensive patients with end-stage renal disease: a single centre experience

C Ott, A Schmid, T Ditting, R Veelken, M Uder… - Clinical and …, 2019 - Springer
Background Sympathetic nerve activity is a hallmark of hypertension in end-stage renal
disease (ESRD). An initial proof-of-concept study implies that renal denervation (RDN) is …

Effects of renal denervation on blood pressure in hypertensive patients with end-stage renal disease: a single centre experience.

C Ott, A Schmid, T Ditting, R Veelken… - Clinical & …, 2019 - search.ebscohost.com
Background: Sympathetic nerve activity is a hallmark of hypertension in end-stage renal
disease (ESRD). An initial proof-of-concept study implies that renal denervation (RDN) is …

Effects of renal denervation on blood pressure in hypertensive patients with end-stage renal disease: a single centre experience

C Ott, A Schmid, T Ditting, R Veelken… - Clinical and …, 2019 - pubmed.ncbi.nlm.nih.gov
Background Sympathetic nerve activity is a hallmark of hypertension in end-stage renal
disease (ESRD). An initial proof-of-concept study implies that renal denervation (RDN) is …

Effects of renal denervation on blood pressure in hypertensive patients with end-stage renal disease: a single centre experience.

C Ott, A Schmid, T Ditting, R Veelken… - Clinical and …, 2019 - europepmc.org
Background Sympathetic nerve activity is a hallmark of hypertension in end-stage renal
disease (ESRD). An initial proof-of-concept study implies that renal denervation (RDN) is …

Effects of renal denervation on blood pressure in hypertensive patients with end-stage renal disease: a single centre experience

C Ott, A Schmid, T Ditting, R Veelken… - Clinical and …, 2019 - search.proquest.com
Background Sympathetic nerve activity is a hallmark of hypertension in end-stage renal
disease (ESRD). An initial proof-of-concept study implies that renal denervation (RDN) is …